AzurRx BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch AZRX and buy or sell other stocks, ETFs, and their options commission-free!About AZRX
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
CEOJason D. Sawyer
CEOJason D. Sawyer
Employees2
Employees2
HeadquartersBoca Raton, Florida
HeadquartersBoca Raton, Florida
Founded2014
Founded2014
Employees2
Employees2
AZRX Key Statistics
Market cap3.43M
Market cap3.43M
Price-Earnings ratio-0.44
Price-Earnings ratio-0.44
Dividend yield—
Dividend yield—
Average volume204.95K
Average volume204.95K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.84
52 Week high$5.84
52 Week low$0.9693
52 Week low$0.9693
Stock Snapshot
AzurRx BioPharma(AZRX) stock is priced at $2.16, giving the company a market capitalization of 3.43M. It carries a P/E multiple of -0.44.
On 2025-11-25, AzurRx BioPharma(AZRX) stock opened at —, reached a high of —, and a low of —.
AzurRx BioPharma(AZRX) shares are trading with a volume of 0, against a daily average of 204.95K.
During the past year, AzurRx BioPharma(AZRX) stock moved between $0.97 at its lowest and $5.84 at its peak.
During the past year, AzurRx BioPharma(AZRX) stock moved between $0.97 at its lowest and $5.84 at its peak.
People also own
Based on the portfolios of people who own AZRX. This list is generated using Robinhood data, and it’s not a recommendation.